T-Cell Senescence in Human Metabolic Diseases
Diabetes & Metabolism Journal · 30.09.2024 · 48 (5) · 864-881
DOI: 10.4093/dmj.2024.0140 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes & Metabolism Journal, erschienen am 30.09.2024. Verfasst von Ha Thi Nga und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Endocrinology and Immune System, Chungnam National University College of Medicine, Daejeon, Korea. Hauptthemen laut MEDLINE: Cellular Senescence, Metabolic Diseases, T-Lymphocytes, Insulin Resistance. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Chungnam National University, National Research Foundation of Korea, Ministry of Science, ICT and Future Planning.
Abstract (Originalsprache)
Immunosenescence denotes a state of dysregulated immune cell function characterized by a confluence of factors, including arrested cell cycle, telomere shortening, markers of cellular stress, mitochondrial dysfunction, loss of proteostasis, epigenetic reprogramming, and secretion of proinflammatory mediators. This state primarily manifests during the aging process but can also be induced in various pathological conditions, encompassing chronic viral infections, autoimmune diseases, and metabolic disorders. Age-associated immune system alterations extend to innate and adaptive immune cells, with T-cells exhibiting heightened susceptibility to immunosenescence. In particular, senescent T-cells have been identified in the context of metabolic disorders such as obesity, diabetes, and cardiovascular diseases. Recent investigations suggest a direct link between T-cell senescence, inflammation, and insulin resistance. The perturbation of biological homeostasis by senescent T-cells appears intricately linked to the initiation and progression of metabolic diseases, particularly through inflammation-mediated insulin resistance. Consequently, senescent T-cells are emerging as a noteworthy therapeutic target. This review aims to elucidate the intricate relationship between metabolic diseases and T-cell senescence, providing insights into the potential roles of senescent T-cells in the pathogenesis of metabolic disorders. Through a comprehensive examination of current research findings, this review seeks to contribute to a deeper understanding of the complex interplay between immunosenescence and metabolic health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Endocrinology and Immune System, Chungnam National University College of Medicine, Daejeon, Korea.
- Department of Medical Science, Chungnam National University College of Medicine, Daejeon, Korea.
- Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Förderung
- Chungnam National University
- National Research Foundation of Korea
- Ministry of Science, ICT and Future Planning
- Chungnam National University Hospital
- Korea Health Industry Development Institute
- Ministry of Health and Welfare
Zitieren
APA
Nga, H. T., Nguyen, T. L., & Yi, H. S. (2024). T-Cell Senescence in Human Metabolic Diseases. Diabetes & Metabolism Journal, 48(5), 864-881. https://doi.org/10.4093/dmj.2024.0140
Vancouver
Nga HT, Nguyen TL, Yi HS. T-Cell Senescence in Human Metabolic Diseases. Diabetes & Metabolism Journal. 2024;48(5):864-881. doi:10.4093/dmj.2024.0140
BibTeX
@article{Nga2024,
author = {Nga, Ha Thi and Nguyen, Thi Linh and Yi, Hyon-Seung},
title = {T-Cell Senescence in Human Metabolic Diseases},
journal = {Diabetes & Metabolism Journal},
year = {2024},
volume = {48},
number = {5},
pages = {864--881},
doi = {10.4093/dmj.2024.0140}
}
EUVIMED